Latest Erythropoietin Stories
HORSHAM, Pa., June 24, 2011 /PRNewswire/ -- Janssen Products, LP, formerly Centocor Ortho Biotech Products, L.P., today announced updated prescribing information for PROCRITÂ® (Epoetin alfa) when used to treat anemia associated with chronic kidney disease (CKD) as part of a U.S.
THOUSAND OAKS, Calif., June 24, 2011 /PRNewswire/ -- Amgen (NASDAQ: AMGN) announced today that the U.S.
Cites increased risk of cardiovascular events when used to treat chronic kidney disease SILVER SPRING, Md., June 24, 2011 /PRNewswire-USNewswire/ -- The U.S.
NES-ZIONA, Israel, June 20, 2011 /PRNewswire/ -- PROLOR Biotech, Inc.
NES-ZIONA, Israel, June 13, 2011 /PRNewswire/ -- PROLOR Biotech, Inc. (NYSE Amex: PBTH), today announced that the U.S. Patent and Trademark Office (PTO) has allowed a new patent for the company's veterinary version of its long-acting CTP-enhanced non-human growth hormone (NhGH-CTP).
NES-ZIONA, Israel, June 6, 2011 /PRNewswire/ -- PROLOR Biotech, Inc. (NYSE Amex: PBTH) today reported positive results from a comparative animal study of its long-acting anti-obesity drug candidate oxyntomodulin (OXY-RPEG).
Making prescription drugs affordable EDMONTON, June 1, 2011 /PRNewswire/ - Compass Biotechnologies (COBI:OB) is a product-oriented, specialty biopharmaceutical company focused on developing products forÂ multi-billion dollar markets.
NES-ZIONA, Israel, May 23, 2011 /PRNewswire/ -- PROLOR Biotech, Inc.
THOUSAND OAKS, Calif., May 18, 2011 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that data from studies involving nine Amgen products will be presented at the 2011 American Society of Clinical Oncology (ASCO) Annual Meeting, June 3 - 7, 2011 in Chicago.
SAN DIEGO, May 13, 2011 /PRNewswire/ -- ViaCyte, Inc., a preclinical cell therapy company focused on diabetes, today announced the appointment of Anthony ("Tony") Gringeri as Chief Development Officer. Dr.
- A trick or prank.